Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Oncology Patients Receiving Chemotherapy × Diphenhydramine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 4 Neoplasms 3 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Stomatitis 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oncology Patients Receiving Chemotherapy 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

ofatumumab 1 ocrelizumab 1 obinutuzumab 1 ibritumomab tiuxetan 1 Rituximab 1 Paclitaxel 1 Diphenhydramine 1 Cetirizine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04189588 2023-10-06

versus

TerSera Therapeutics LLC

Phase 2 Completed

34 enrolled 11 charts

Oncology Patients Receiving Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡